GTE to market Vidimedix offering

Article

GTE to market Vidimedix offeringTelecommunications firm GTE and telemedicine software developer VidiMedix have formed a strategic alliance to market the VidiMedix Series 1000 PC-based telemedicine system. The system, which has received Food and

GTE to market Vidimedix offering

Telecommunications firm GTE and telemedicine software developer VidiMedix have formed a strategic alliance to market the VidiMedix Series 1000 PC-based telemedicine system. The system, which has received Food and Drug Administration 510(k) clearance, allows real-time remote patient/physician interaction and full-feature medical imaging, according to Austin, TX-based VidiMedix. VidiMedix 1000 consists of a group of desktop computer workstations that send, receive, and store a variety of medical information and images. Medical image and information can be simultaneously viewed, marked, and annotated with the system's whiteboarding and audio recording capabilities, according to the firm.

In other VidiMedix news, the company will participate in the Microsoft Certified Solution Provide program, which was formed by Microsoft to facilitate partnerships with information technology companies. VidiMedix is building upon Microsoft's forthcoming database technology to expand telemedicine beyond simple point-to-point connections, according to the firm. n

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.